These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 29237267)
1. Unsaturated Squalene Content in Emulsion Vaccine Adjuvants Plays a Crucial Role in ROS-Mediated Antigen Uptake and Cellular Immunity. Huang CH; Huang CY; Huang MH Mol Pharm; 2018 Feb; 15(2):420-429. PubMed ID: 29237267 [TBL] [Abstract][Full Text] [Related]
2. Feasibility of Freeze-Drying Oil-in-Water Emulsion Adjuvants and Subunit Proteins to Enable Single-Vial Vaccine Drug Products. Iyer V; Cayatte C; Marshall JD; Sun J; Schneider-Ohrum K; Maynard SK; Rajani GM; Bennett AS; Remmele RL; Bishop SM; McCarthy MP; Muralidhara BK J Pharm Sci; 2017 Jun; 106(6):1490-1498. PubMed ID: 28259764 [TBL] [Abstract][Full Text] [Related]
3. Squalane-based emulsion vaccine delivery system: composition with murabutide activate Th1 response. Kantipakala R; Bonam SR; Vemireddy S; Miryala S; Halmuthur M SK Pharm Dev Technol; 2019 Mar; 24(3):269-275. PubMed ID: 29688119 [TBL] [Abstract][Full Text] [Related]
4. Squalene and squalane emulsions as adjuvants. Allison AC Methods; 1999 Sep; 19(1):87-93. PubMed ID: 10525443 [TBL] [Abstract][Full Text] [Related]
5. Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(γ-glutamic acid) nanoparticles. Shima F; Akagi T; Uto T; Akashi M Biomaterials; 2013 Dec; 34(37):9709-16. PubMed ID: 24016848 [TBL] [Abstract][Full Text] [Related]
6. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect. Calabro S; Tritto E; Pezzotti A; Taccone M; Muzzi A; Bertholet S; De Gregorio E; O'Hagan DT; Baudner B; Seubert A Vaccine; 2013 Jul; 31(33):3363-9. PubMed ID: 23684834 [TBL] [Abstract][Full Text] [Related]
7. Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion. Haensler J; Probeck P; Su J; Piras F; Dalençon F; Cotte JF; Chambon V; Iqbal SM; Hawkins L; Burdin N Int J Pharm; 2015; 486(1-2):99-111. PubMed ID: 25794609 [TBL] [Abstract][Full Text] [Related]
8. Antigen delivery for cross priming via the emulsion vaccine adjuvants. Shen SS; Yang YW Vaccine; 2012 Feb; 30(9):1560-71. PubMed ID: 22230588 [TBL] [Abstract][Full Text] [Related]
9. Development of Squalene-Based Oil-in-Water Emulsion Adjuvants Using a Self-Emulsifying Drug Delivery System for Enhanced Antigen-Specific Antibody Titers. Chae GE; Kim DW; Jin HE Int J Nanomedicine; 2022; 17():6221-6231. PubMed ID: 36531114 [TBL] [Abstract][Full Text] [Related]
11. A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation. Deng J; Cai W; Jin F Int J Pharm; 2014 Jul; 468(1-2):187-95. PubMed ID: 24704309 [TBL] [Abstract][Full Text] [Related]
12. Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake. Liang F; Lindgren G; Sandgren KJ; Thompson EA; Francica JR; Seubert A; De Gregorio E; Barnett S; O'Hagan DT; Sullivan NJ; Koup RA; Seder RA; Loré K Sci Transl Med; 2017 Jun; 9(393):. PubMed ID: 28592561 [TBL] [Abstract][Full Text] [Related]
13. Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family. Fox CB; Van Hoeven N; Granger B; Lin S; Guderian JA; Hartwig A; Marlenee N; Bowen RA; Soultanov V; Carter D Phytomedicine; 2019 Nov; 64():152927. PubMed ID: 31465981 [TBL] [Abstract][Full Text] [Related]
14. Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants. Iyer V; Cayatte C; Guzman B; Schneider-Ohrum K; Matuszak R; Snell A; Rajani GM; McCarthy MP; Muralidhara B Hum Vaccin Immunother; 2015; 11(7):1853-64. PubMed ID: 26090563 [TBL] [Abstract][Full Text] [Related]
15. Vaccine adjuvant MF59 promotes the intranodal differentiation of antigen-loaded and activated monocyte-derived dendritic cells. Cioncada R; Maddaluno M; Vo HTM; Woodruff M; Tavarini S; Sammicheli C; Tortoli M; Pezzicoli A; De Gregorio E; Carroll MC; D'Oro U; Piccioli D PLoS One; 2017; 12(10):e0185843. PubMed ID: 29088224 [TBL] [Abstract][Full Text] [Related]
16. An alternative renewable source of squalene for use in emulsion adjuvants. Brito LA; Chan M; Baudner B; Gallorini S; Santos G; O'Hagan DT; Singh M Vaccine; 2011 Aug; 29(37):6262-8. PubMed ID: 21723355 [TBL] [Abstract][Full Text] [Related]
17. Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice. Zhang J; Miao J; Han X; Lu Y; Deng B; Lv F; Zhao Y; Ding C; Hou J BMC Vet Res; 2018 Dec; 14(1):415. PubMed ID: 30577861 [TBL] [Abstract][Full Text] [Related]
18. Impact of antigen-adjuvant associations on antigen uptake and antigen-specific humoral immunity in mice following intramuscular injection. Huang CH; Huang CY; Huang MH Biomed Pharmacother; 2019 Oct; 118():109373. PubMed ID: 31545268 [TBL] [Abstract][Full Text] [Related]
19. An immunopotentiator, ophiopogonin D, encapsulated in a nanoemulsion as a robust adjuvant to improve vaccine efficacy. Tong YN; Yang LY; Yang Y; Song Z; Peng LS; Gao JN; Zeng H; Zou QM; Sun HW; Mao XH Acta Biomater; 2018 Sep; 77():255-267. PubMed ID: 30031164 [TBL] [Abstract][Full Text] [Related]
20. Squalene-based oil-in-water emulsion adjuvants perturb metabolism of neutral lipids and enhance lipid droplet formation. Kalvodova L Biochem Biophys Res Commun; 2010 Mar; 393(3):350-5. PubMed ID: 20018176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]